Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

2% Minoxidil does not prevent hair loss during chemotherapy.

Sacituzumab Tirumotecan shows promise in treating gynecologic cancers with manageable side effects.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Chemotherapy reduces taste and smell, but they mostly recover after treatment; adding spices may help improve appetite.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

New skin lesions on the scrotum or vulva in patients with a history of internal cancer could indicate rare skin metastasis.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Chemotherapy is crucial for treating gynecological cancers but requires careful management due to severe side effects.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

Scalp cooling reduces hair loss and improves quality of life during chemotherapy.

Scalp cooling therapy helps preserve hair during chemotherapy for most patients.

Hair loss can indicate or worsen with systemic diseases, and treating the underlying condition is important.

Cell-mediated drug delivery systems improve skin disease treatment by using living cells for precise, prolonged, and less toxic therapy.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

5-alpha reductase inhibitors and spironolactone don't increase gynecological tumor risk, glucagon-like-peptide-1 receptor agonists may increase alopecia risk, sanitary pads can cause dermatitis, early hidradenitis suppurativa intervention is crucial for Hispanic patients, community education boosts skin cancer awareness, metformin may improve skin cancer survival, LNG-IUDs can increase acne risk, machine learning accurately detects basal cell carcinoma, JAK-inhibitors may raise miscarriage risk, inclusive skincare ads affect those with darker skin, and CCCA in Black women might involve autoimmunity.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Some ovarian tumors can cause masculinization, and it's important to check for various causes when this symptom is present.

ADAM17 could be a potential target for treating PCOS.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Chemotherapy often causes hair loss in cancer patients, affecting their mental health, but scalp cooling can help prevent it.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

PCOS is linked to a higher risk of endometrial cancer but not ovarian or breast cancer, and more research is needed on its role in cancer development and treatment effects.

A young woman had a rare tumor causing high male hormone levels and symptoms like excessive hair and acne. After removing the tumor, her hormone levels returned to normal. Early diagnosis is important.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

PCOS is a common and costly condition in North American women, causing various health issues like obesity, diabetes, and fertility problems.

Werner's syndrome causes early aging and increases cancer risk, requiring early diagnosis and symptom management.

Alopecia treatments like 5α-reductase inhibitors and spironolactone are safe for breast cancer patients and high-risk women.

PCOS involves hormonal and metabolic issues, increasing risks for diabetes and heart disease, and requires lifestyle changes and medication for management.

Testosterone therapy seems safe and effective for transgender men with proper care, but more long-term research is needed.

A woman's male-like physical changes were caused by two rare ovarian conditions.